1.Clinical Significance of Vascular Endothelial Growth Factors (VEGF)-C and -D in Resected Non-Small Cell Lung Cancer.
Yoon Ho KO ; Chan Kwon JUNG ; Myung Ah LEE ; Jae Ho BYUN ; Jin Hyoung KANG ; Kyo Young LEE ; Keon Hyun JO ; Young Pil WANG ; Young Seon HONG
Cancer Research and Treatment 2008;40(3):133-140
PURPOSE: Lymphatic spread of tumor is an important prognostic factor for patients with non-small cell lung carcinoma (NSCLC). Vascular endothelial growth factor-C (VEGF-C) and VEGF-D play important roles in lymphangiogenesis via the VEGF receptor 3 (VEGFR-3). We sought to determine whether VEGF-C, VEGF-D and VEGFR-3 are involved in the clinical outcomes of patients with resected NSCLC. MATERIALS AND METHODS: Using immunohistochemical staining, we investigated the protein expressions of VEGF-C, VEGF-D and VEGFR-3 in the tissue array specimens from patients who underwent resection for NSCLC. The immunoreactivity for p53 was also examined. The clinicopathological implications of these molecules were statistically analyzed. RESULTS: Analysis of a total of 118 specimens showed that VEGF-C, VEGF-D and their co-expression were significantly associated with more advanced regional lymph node metastasis (p=0.019, p=0.044 and p=0.026, respectively, N2 versus N0 and N1). A VEGFR-3 expression had a strong correlation with peritumoral lymphatic invasion (p=0.047). On the multivariate analysis for survival and recurrence, pathologic N2 lymph node metastasis was the only independent prognostic factor, but none of the investigated molecules showed any statistical correlation with recurrence and survival. CONCLUSIONS: The present study revealed that high expressions of VEGF-C and VEGF-D were strongly associated with more advanced regional lymph node metastasis in patients with resected NSCLC.
Carcinoma, Non-Small-Cell Lung
;
Humans
;
Lung
;
Lymph Nodes
;
Lymphangiogenesis
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Receptors, Vascular Endothelial Growth Factor
;
Recurrence
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factor C
;
Vascular Endothelial Growth Factor D
;
Vascular Endothelial Growth Factor Receptor-3
;
Vascular Endothelial Growth Factors
2.Correlation of Vascular Endothelial Growth Factor-D Expression and VEGFR-3-Positive Vessel Density with Lymph Node Metastasis in Gastric Carcinoma.
Jung Hye CHOI ; Young Ha OH ; Yong Wook PARK ; Hong Kyu BAIK ; Young Yiul LEE ; In Soon KIM
Journal of Korean Medical Science 2008;23(4):592-597
Lymph node metastasis is an important prognostic factor in gastric cancer. Vascular endothelial growth factor-D (VEGF-D) is a lymphangiogenic growth factor that activates VEGF receptor (VEGFR)-3, a receptor expressed in the lymphatic endothelium. We investigated the clinical value of VEGF-D expression and VEGFR-3 positive vessel density in gastric carcinoma with regard to lymphangiogenesis. Immunohistochemical staining was used to determine the expression of VEGF-D and VEGFR- 3 in specimens from 104 cases of resected gastric cancer. VEGF-D expression was observed in 62.5% of the gastric cancers and in 9.6% of the non-neoplastic gastric tissue. The VEGFR-3-positive vessel density was significantly greater in the VEGFD positive group than the negative group. VEGF-D expression was significantly associated with lymph node metastasis, increased serum CEA levels, and the nonsignet ring cell type. The VEGFR-3-positive vessel density was correlated with tumor size, lymphatic invasion, and lymph node metastasis. The VEGF-D expression and high VEGFR-3-positive vessel density were significant poor prognostic factors for relapse-free survival. These results suggest that VEGF-D and VEGFR-3-positive vessel density are potential molecular markers that predict lymphatic involvement in gastric carcinoma.
Adult
;
Aged
;
Female
;
Humans
;
Immunohistochemistry
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Prognosis
;
Stomach Neoplasms/*blood supply/chemistry/*pathology
;
Vascular Endothelial Growth Factor D/*analysis
;
Vascular Endothelial Growth Factor Receptor-3/*analysis
3.The Effect of Caffeine on 3T3-L1 Adipocyte Differentiation : A Nutrigenomical Approach.
Mi Ja KIM ; Youngok KIM ; Joo Ho CHUNG ; Jong Woo KIM ; Hye Kyung KIM
The Korean Journal of Nutrition 2005;38(8):649-655
Nutrigenomics refers to research that investigates the interaction between nutrition and the human genome. Caffeine in tea and coffee is widely and routinely consumed by people. This study was performed to confirm the effect of caffeine treatment on the gene expression and cytokine profiling in 3T3-L1 adipocyte cells using microarray and protein array methodology. Treatment of caffeine in 3T3-L1 adipocyte cells increased expression of several genes related with obesity including adipocyte C1Q and collagen domain containing (ACDC), Adipsin (ADN), uncoupling protein 3 (UCP3), while glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which is known as lipid storage enzyme, was decreased by caffeine treatment. Furthermore, cytokines, such as interleukin-3 (IL-3), interleukin-12 (IL-12), interleukin-13 (IL-13), granulocyte colony stimulating factor (GCSF), granulocyte macrophage colony stimulating factor (GM-CSF) and vascular endothelial growth factor (VEGF), were decreased in caffeine treated 3T3-L1 adipocyte cells. These results provided interesting information about the genes related with caffeine and cytokine expression profiling in obesity.
Adipocytes*
;
Caffeine*
;
Coffee
;
Collagen
;
Colony-Stimulating Factors
;
Complement Factor D
;
Cytokines
;
Gene Expression
;
Genome, Human
;
Granulocyte-Macrophage Colony-Stimulating Factor
;
Granulocytes
;
Humans
;
Interleukin-12
;
Interleukin-13
;
Interleukin-3
;
Nutrigenomics
;
Obesity
;
Oxidoreductases
;
Protein Array Analysis
;
Tea
;
Vascular Endothelial Growth Factor A